Real-time enrollment status for this blood clots clinical trial
Current Status
Completed
Checked: April 18, 2026 at 12:23 AM UTC
| NCT Number | NCT06299111 |
| Recruiting Status | Completed |
| Condition | Blood Clots |
| Phase | Clinical Trial |
| Target Enrollment | 195 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | April 13, 2026 (5 days ago) |
As of April 18, 2026: Clinical trial NCT06299111 is currently completed participants. This clinical trial study for blood clots is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06299111 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06299111 was last updated 5 days ago (April 13, 2026). HelloStudys verifies this status automatically.